Enanta Pharmaceuticals (ENTA) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ENTA is expected to report earnings to rise 4.67% to -112 cents per share on November 25

Enanta Pharmaceuticals ENTA Stock Earnings Reports

Q3'24

Est.

$-1.12

Q2'24

Beat

by $0.36

Q1'24

Missed

by $0.13

Q4'23

Missed

by $1.75

Q3'23

Beat

by $0.79

The last earnings report on August 05 showed earnings per share of -107 cents, beating the estimate of -142 cents. With 280.26K shares outstanding, the current market capitalization sits at 212.95M.

View a ticker or compare two or three

Compare

ENTA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ENTA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ENTA (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

500 Arsenal Street

Phone

+1 617 607-0800

Employees

145

Web

https://www.enanta.com